1138904

Clofazimine

United States Pharmacopeia (USP) Reference Standard

• Synonim(y): N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine
• Wzór empiryczny (zapis Hilla): C₂₇H₂₂Cl₂N₄
• Numer CAS: 2030-63-9
• Masa cząsteczkowa: 473.40
• NACRES: NA.24
• PubChem Substance ID: 329749427
• UNSPSC Code: 41116107
• MDL number: MFCD00056793

Właściwości

• InChI: 1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3/b30-24+
• SMILES string: CC(C)\N=C1/C=C2N(c3ccc(Cl)cc3)c4ccccc4N=C2C=C1Nc5ccc(Cl)cc5
• InChI key: WDQPAMHFFCXSNU-BGABXYSRSA-N
• grade: pharmaceutical primary standard
• API family: clofazimine
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat

Opis

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Clofazimine USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Clofazimine Capsules

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Disclaimer

Sales restrictions may apply.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable